Search results
Showing 1 to 3 of 3 results for palforzia
Palforzia for treating peanut allergy in children and young people (TA769)
Evidence-based recommendations on Palforzia for treating peanut allergy in children and young people.
Palforzia for treating peanut allergy in children aged 1 to 3 [ID6144]
In development [GID-TA11070] Expected publication date: TBC
Children and young people set to benefit from new treatment for peanut allergy
Children and young people aged between 4 and 17 with a peanut allergy could be set to benefit from Palforzia, a new treatment which can help build up their tolerance to peanut, after NICE recommended its use in draft guidance published today (23 December 2021).